<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="retraction" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Pathol. Oncol. Res.</journal-id>
<journal-title>Pathology &#x26; Oncology Research</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Pathol. Oncol. Res.</abbrev-journal-title>
<issn pub-type="epub">1532-2807</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1611767</article-id>
<article-id pub-id-type="doi">10.3389/pore.2024.1611767</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pathology and Oncology Archive</subject>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Retraction: MiR-184 retarded the proliferation, invasiveness and migration of glioblastoma cells by repressing stanniocalcin-2</article-title>
<alt-title alt-title-type="left-running-head">Pathology &#x26; Oncology Research Editorial Office</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/pore.2024.1611767">10.3389/pore.2024.1611767</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<collab>Pathology &#x26; Oncology Research Editorial Office</collab>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/983694/overview"/>
</contrib>
</contrib-group>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Approved by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/701717/overview">J&#xf3;zsef T&#xed;m&#xe1;r</ext-link>, Semmelweis University, Hungary</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Pathology &#x26; Oncology Research Editorial Office, <email>editorialoffice@por-journal.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>30</volume>
<elocation-id>1611767</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Pathology &#x26; Oncology Research Editorial Office.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Pathology &#x26; Oncology Research Editorial Office</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="retracted-article" journal-id="Pathol. Oncol. Res." journal-id-type="nlm-ta" xlink:href="10.1007/s12253-017-0298-z" ext-link-type="doi">A Retraction of the Original Article <article-title>MiR-184 retarded the proliferation, invasiveness and migration of glioblastoma cells by repressing stanniocalcin-2</article-title> by Feng L, Ma J, Ji H, Liu Y and Hu W (2018). Pathol. Oncol. Res. 24:853&#x2013;860. doi: <object-id>10.1007/s12253-017-0298-z</object-id>
</related-article>
</article-meta>
</front>
<body>
<p>Following publication, concerns were raised on the PubPeer platform regarding the validity of the data in the article. An investigation by the Editorial Office, conducted in accordance with Pathology and Oncology Research policies, was unable to confirm the validity of the data presented and as such cannot confirm its reliability. The article is therefore retracted.</p>
<p>This retraction was approved by the Editor-in-Chief of Pathology and Oncology Research. The authors received communication regarding the retraction but did not respond. The communication has been recorded by the publisher.</p>
<p>Pathology and Oncology Research would like to thank the concerned reader who contacted us regarding the published article.</p>
</body>
</article>